Loading live market data…

Galectin Therapeutics Inc.

NASDAQ:GALT

$4.76 USD

-$0.58 (-10.86%)

Volume
528.8K
Average Volume
609.99K
Market Capitalization
$313.48M
P/E Ratio
-11.70
Dividend Yield
0.00%
Price Target
$11.00
Year High
$7.13
Year Low
$2.03
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$2.15

GALT Estimated and Actual Revenue by Quarter

GALT Estimated and Actual EPS by Quarter

GALT Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
2026-06-30 0 - - - - - -
2026-03-31 0 - - - - - -
2025-12-31 1 - - - - - -
2025-09-30 0 - - - - - -
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-31 0 -6.58M -6.58M -6.58M - - -
2026-09-30 0 -6.58M -6.58M -6.58M - - -
2026-06-30 0 -5.92M -5.92M -5.92M - - -
2026-03-31 0 -3.95M -3.95M -3.95M - - -
2025-12-31 1 -6.58M -6.58M -6.58M - - -
2025-09-30 0 -7.06M -7.06M -7.06M - - -
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-31 0 - - - 1 -0.1 -0.1 -0.1
2026-09-30 0 - - - 1 -0.1 -0.1 -0.1
2026-06-30 0 - - - 1 -0.09 -0.09 -0.09
2026-03-31 0 - - - 1 -0.06 -0.06 -0.06
2025-12-31 1 36.32M 36.32M 36.32M 1 -0.1 -0.1 -0.1
2025-09-30 0 - - - 1 -0.11 -0.11 -0.11